Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3

被引:136
|
作者
Gui, Chunshan [1 ]
Miao, Yi [1 ]
Thompson, Lucas [1 ]
Wahlgren, Bret [1 ]
Mock, Melissa [3 ]
Stieger, Bruno [3 ]
Hagenbuch, Bruno [1 ,2 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Kansas Mason Canc Res Inst, Kansas City, KS 66103 USA
[3] Univ Zurich Hosp, Dept Med, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland
关键词
organic anion transporting polypeptide; hepatocyte; drug-drug interaction; nuclear receptor ligand;
D O I
10.1016/j.ejphar.2008.01.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pregnane X receptor is a ligand-activated transcription factor that is abundantly expressed in hepatocytes. Numerous drugs are pregnane X receptor ligands. To bind to their receptor they must cross the sinusoidal membrane. Organic anion transporting polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) are polyspecific transporters expressed at the sinusoidal membrane of human hepatocytes. They mediate transport of a variety of drugs including the pregnane X receptor ligands rifampicin and dexamethasone. To test whether additional pregnane X receptor ligands interact with OATP1B1 - and 1B3-mediated transport, we developed Chinese Hamster Ovary (CHO) cell lines stably expressing OATP1B1 or 1B3 at high levels. OATP1B1- and 1B3-mediated estradiol-17 beta-glucuronide uptake was inhibited by several pregnane X receptor ligands in a concentration dependent way. IC50 values for rifampicin, paclitaxel, mifepristone, and troglitazone were within their respective pharmacological free plasma concentrations. Kinetic analysis revealed that clotrimazole inhibits OATP1B1-mediated estradiol-17 beta-glucuronide transport with a K-i of 7.7 +/- 0.3 mu M in a competitive way. However, uptake of OATP1B3-mediated estradiol-17 beta-glucuronide was stimulated and this stimulation was due to an increased apparent affinity. Transport of estrone-3-sulfate was hardly affected while all other substrates tested were inhibited. Additional azoles like fluconazole, ketoconazole and miconazole did not stimulate OATP1B3-mediated estradiol-17 beta-glucuronide transport. In summary, these results demonstrate that pregnane X receptor ligands, by inhibiting or stimulating OATP-mediated uptake, can lead to drug-drug interactions at the transporter level. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 50 条
  • [31] Expression of the organic anion transporters OATP1B1, OATP1B3, and OATP2B1 in human liver is affected by genetic and nongenetic factors
    Nies, A.
    Winter, S.
    Burk, O.
    Klein, K.
    Zanger, U. M.
    Stieger, B.
    Schwab, M.
    Schaeffeler, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 80 - 80
  • [32] Transport by OATP1B1 and OATP1B3 Enhances the Cytotoxicity of Epigallocatechin 3-O-Gallate and Several Quercetin Derivatives
    Zhang, Yuchen
    Hays, Amanda
    Noblett, Alexander
    Thapa, Mahendra
    Hua, Duy H.
    Hagenbuch, Bruno
    JOURNAL OF NATURAL PRODUCTS, 2013, 76 (03): : 368 - 373
  • [33] Selectivity and Potency of Microcystin Congeners against OATP1B1 and OATP1B3 Expressing Cancer Cells
    Niedermeyer, Timo H. J.
    Daily, Abigail
    Swiatecka-Hagenbruch, Monika
    Moscow, Jeffrey A.
    PLOS ONE, 2014, 9 (03):
  • [34] In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia
    Chiou, William J.
    de Morais, Sonia M.
    Kikuchi, Ryota
    Voorman, Richard L.
    Li, Xiaofeng
    Bow, Daniel A. J.
    XENOBIOTICA, 2014, 44 (03) : 276 - 282
  • [35] Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis
    Chen, Lin
    Liu, Linlin
    Chen, Yu
    Liu, Mingyi
    Xiong, Yuqing
    Zhang, Hong
    Huang, Shibo
    Xia, Chunhua
    XENOBIOTICA, 2019, 49 (10) : 1221 - 1228
  • [36] Kinetic Characterization of Fluorescein Uptake In Human Cryopreserved Hepatocytes and in OATP1B1 and OATP1B3 Transfected CHO Cells
    De Bruyn, Tom
    Fattah, Sarinj
    Stieger, Bruno
    Augustijns, Patrick
    Annaert, Pieter
    DRUG METABOLISM REVIEWS, 2010, 42 : 291 - 292
  • [37] Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3
    Schnegelberger, Regina D. D.
    Steiert, Brianna
    Sandoval, Philip J. J.
    Hagenbuch, Bruno
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [38] Suppression of OATP1B1, OATP1B3, and OATP 2B1 transporters in primary cryopreserved human hepatocytes following lipid delivery of stealth siRNA
    Grepper, Susan
    Vozza-Brown, Laura
    Sahi, Jasminder
    DRUG METABOLISM REVIEWS, 2009, 41 : 175 - 176
  • [39] The Roles of MRP2, MRP3, OATP1B1, and OATP1B3 in Conjugated Hyperbilirubinemia
    Keppler, Dietrich
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (04) : 561 - 565
  • [40] Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP1B1, OATP1B3, OATP2B1 and NTCP
    Koenig, Joerg
    Klatt, Sabine
    Dilger, Karin
    Fromm, Martin F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (02) : 81 - 86